- Home
- ECBK vs SCPH Comparison
ECBK vs SCPH Comparison
Compare ECBK & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECBK
- SCPH
- Stock Information
- Founded
- ECBK 1919
- SCPH 2013
- Country
- ECBK United States
- SCPH United States
- Employees
- ECBK N/A
- SCPH N/A
- Industry
- ECBK Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- ECBK Finance
- SCPH Health Care
- Exchange
- ECBK Nasdaq
- SCPH Nasdaq
- Market Cap
- ECBK 151.0M
- SCPH 173.6M
- IPO Year
- ECBK N/A
- SCPH 2017
- Fundamental
- Price
- ECBK $15.83
- SCPH $5.25
- Analyst Decision
- ECBK
- SCPH Strong Buy
- Analyst Count
- ECBK 0
- SCPH 3
- Target Price
- ECBK N/A
- SCPH $14.00
- AVG Volume (30 Days)
- ECBK 15.7K
- SCPH 315.0K
- Earning Date
- ECBK 07-24-2025
- SCPH 08-13-2025
- Dividend Yield
- ECBK N/A
- SCPH N/A
- EPS Growth
- ECBK 52.06
- SCPH N/A
- EPS
- ECBK 0.64
- SCPH N/A
- Revenue
- ECBK $27,795,000.00
- SCPH $41,982,000.00
- Revenue This Year
- ECBK N/A
- SCPH $108.95
- Revenue Next Year
- ECBK N/A
- SCPH $73.83
- P/E Ratio
- ECBK $25.16
- SCPH N/A
- Revenue Growth
- ECBK 12.29
- SCPH 138.10
- 52 Week Low
- ECBK $12.50
- SCPH $1.94
- 52 Week High
- ECBK $16.99
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- ECBK 47.35
- SCPH 63.11
- Support Level
- ECBK $15.97
- SCPH $5.37
- Resistance Level
- ECBK $16.44
- SCPH $6.28
- Average True Range (ATR)
- ECBK 0.37
- SCPH 0.31
- MACD
- ECBK -0.02
- SCPH 0.04
- Stochastic Oscillator
- ECBK 5.88
- SCPH 47.72
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.